Keywords: amylin/lilly, byetta, achieves, glycemic, control, usa, amylin

Amylin/Lilly's Byetta achieves glycemic control

Article | 16 June 2008

Print This

The USA's Amylin Pharmaceuticals and drug major Eli Lilly have reported strong data from a study of patients with type 2 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in